Top Markets
Coin of the day
Ibere Pharmaceuticals Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER
Rank in Stocks #19087
Ibere Pharmaceuticals currently lacks significant operational activities, with... Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Share Price
$10.18
Last synced: 2023-03-01
Market Cap
$175.61M
Change (1 day)
-0.29%
Change (1 year)
0.00%
Country
US
Trade Ibere Pharmaceuticals (IBER)
P/S ratio for Ibere Pharmaceuticals (IBER)
P/S ratio as of 2026 TTM: 0
According to Ibere Pharmaceuticals latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Ibere Pharmaceuticals from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors